A. PROSPECTIVE COHORT STUDIES
■ Korean Registry for Activating Trial on Dementia Therapeutics (KREATE4T) [link]: : Develop a registry of Korean people either with or at risk of dementia who may be eligible to participate in clinical studies on new therapeutics and diagnostics. The eligibility of the participants is being re-evaluated every year.
Principal investigator, ongoing since 2020,
supported by the Korea Dementia Research Center, jointly by the Ministry of Health and Welfare and the Ministry of Science and ICT, Republic of Korea
■ Korean Registry for Activating Trial on Dementia Diagnostics (KREATE4D)
: Develop a cohort of Korean people with normal cognition, mild cognitive impairment, and dementia and construct a database of their clinical, neuropsychological, neuroimaging, and laboratory evaluations, a neuroimaging bank, and a blood biobank. We followed the participants two years after the enrollment.
Principal investigator, ongoing since 2020,
supported by the Korea Dementia Research Center, jointly by the Ministry of Health and Welfare and the Ministry of Science and ICT, Republic of Korea
(PS-TRR is supported by the Korea Health Industry Development Institute, Ministry of Health and Welfare, Republic of Korea)
■ Korean Longitudinal Study on Cognitive Aging and Dementia (KLOSCAD) [link]:
Principal investigator, ongoing since 2009, supported by the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea from 2009 to 2018,
and the Research of Korea Centers for Disease Control and Prevention , Ministry of Health and Welfare from 2019
supported by the Independent Research Grant (IRG) from Pfizer Global Pharmaceuticals
supported by the Korean Health Technology R&D Project, Ministry of Health and Welfare